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ABSTRACT Rho GTPases are important regulators of many cellular processes. Subversion of Rho GTPases is a common infection
strategy employed by many important human pathogens. Enteropathogenic Escherichia coli and enterohemorrhagic Escherichia
coli (EPEC and EHEC) translocate the effector EspH, which inactivates mammalian Rho guanine exchange factors (GEFs), as
well as Map, EspT, and EspM2, which, by mimicking mammalian RhoGEFs, activate Rho GTPases. In this study we found that
EspH induces focal adhesion disassembly, triggers cell detachment, activates caspase-3, and induces cytotoxicity. EspH-induced
cell detachment and caspase-3 activation can be offset by EspT, EspM2, and the Salmonella Cdc42/Rac1 GEF effector SopE,
which remain active in the presence of EspH. EPEC and EHEC therefore use a novel strategy of controlling Rho GTPase activity
by translocating one effector to inactivate mammalian RhoGEFs, replacing themwith bacterial RhoGEFs. This study also ex-
pands the functional range of bacterial RhoGEFs to include cell adhesion and survival.
IMPORTANCE Many human pathogens use a type III secretion system to translocate effectors that can functionally be divided
into signaling, disabling, and countervirulence effectors. Among the signaling effectors are those that activate Rho GTPases,
which play a central role in coordinating actin dynamics. However, many pathogens also translocate effectors with antagonistic
or counteractive functions. For example, Salmonella translocates SopE and SptP, which sequentially turn Rac1 and Cdc42 on
and off. In this paper, we show that enteropathogenic E. coli translocates EspH, which inactivates mammalian RhoGEFs and
triggers cytotoxicity and at the same time translocates the bacterial RhoGEFs EspM2 and EspT, which are insensitive to EspH,
and so neutralizes EspH-induced focal adhesion disassembly, cell detachment, and caspase-3 activation. Our data point to an
intriguing infection strategy in which EPEC and EHEC override cellular Rho GTPase signaling by disabling mammalian Rho-
GEFs and replacing themwith with bacterial RhoGEFs that promote cell adhesion and survival.
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The Rho family of small GTPases, including RhoA, Rac1, andCdc42, are important regulators of actin organization (1), as
well as many other cellular processes, including cell adhesion and
migration, vesicle trafficking, cytokinesis, and apoptosis (2). Rho
GTPases switch between active GTP-bound and inactive GDP-
bound forms. The cycling of these two states is regulated by gua-
nine nucleotide exchange factors (GEFs), which promote dissoci-
ation of GDP and subsequent binding of GTP and GTPase-
activating proteins (GAPs), which enhance the rate of GTP
hydrolysis to GDP, while guanine nucleotide dissociation inhibi-
tors (GDIs) maintain Rho GTPases in an inactive state in the cy-
tosol (1, 2).
An important mediator of focal adhesion (FA) signaling is fo-
cal adhesion kinase (FAK) (3). FAK is a protein-tyrosine kinase
that is implicated in formation of nascent focal complexes at la-
mellipodial protrusions, as well as disassembly of mature focal
adhesions in a dynamic process known as “FA turnover” (3).
FAK-null fibroblasts exhibit highRho activity, reducedmigration,
and severe FA turnover defects (4). The major phosphorylation
site of FAK is Y397, which recruits c-Src to form a FAK-Src sig-
naling complex that then activates multiple signaling pathways
(3). Recent studies have shown that FAK regulates the localized
activity of Rho GTPases by recruiting RhoGEFs and RhoGAPs at
focal adhesion sites to facilitate FA turnover and cell migration
(5).
Several important bacterial pathogens subvert Rho GTPase
signaling by utilizing a type III secretion system (T3SS) to trans-
locate effector proteins into eukaryotic host cells (6). Entero-
pathogenic Escherichia coli (EPEC) and enterohemorrhagic Esch-
erichia coli (EHEC) translocate the effector EspH, which by
binding to tandemDbl homology-pleckstrin homology (DH-PH)
domains of Dbl-family RhoGEFs blocks the activation of RhoGT-
Pases (7). EPEC and EHEC also translocate the effectors Map,
EspM, and EspT, which, based on an invariant Trp-XXX-Glumo-
tif, are grouped with IpgB1 and IpgB2 (Shigella) and SifA and SifB
(Salmonella) into the WxxxE family of effectors (8–11).
Structural analysis ofMap and EspM2 revealed that theWxxxE
effectors share a three-dimensional fold with the Salmonella GEF
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SopE, which catalyzes the exchange of GDP to GTP by binding to
the switch I and II regions of Rho GTPases (12–14). Map exhibits
a GEF activity for Cdc42 (13) and induces transient filopodium
formation at bacterial attachment sites during the early stages of
EPEC infection (15, 16). EspM2 is a bacterial RhoA GEF that
induces stress fiber formation (10, 14), while EspT activates both
Cdc42 and Rac1, leading to formation of membrane ruffles and
lamellipodia (11).
Importantly, EspH was implicated in modulating Map-
induced filopodium kinetics, as deletion of espH results in filopo-
dium persistence and overexpression of EspH inhibits filopodium
formation (17). However, the overall functional relationships be-
tween these effectors during infection are poorly understood.
Moreover, it is not known if EspH can inhibit the activity of the
SopE-like WxxxE effectors; while structurally distinct from
DH-PH eukaryotic RhoGEFs (12), they activate RhoGTPases by a
similar mechanism. The aim of this study was to characterize the
interplay between EspH and bacterial RhoGEFs in the context of
actin remodeling, cell adhesion, and cell death.
RESULTS
EspH induces cell detachment, cytotoxicity, and focal adhesion
disassembly. EspH binds to DH-PH mammalian RhoGEFs and
induces actin cytoskeletal disruption and cell rounding (7, 17).We
further characterized EspH-induced cytotoxicity by assessing the
levels of cell rounding, cell detachment, and lactate dehydroge-
nase (LDH) release. Myc-tagged EspH (Myc-EspH), or Myc-
tagged green fluorescent protein (Myc-GFP) as a control, was ec-
topically expressed for 24 h, and the levels of cell rounding were
quantified by immunofluorescence microscopy. Cells transfected
with Myc-EspH showed a marked increase in cell rounding com-
pared to those transfected with Myc-GFP (Fig. 1A).
The level of cell detachment followingMyc-EspH orMyc-GFP
expression wasmeasured and quantified as the percentage of total
cells. Myc-EspH was found to induce 45.8  5.5% cell detach-
ment, compared to 8.2  5.0% cell detachment in the Myc-GFP
control (Fig. 1B). A cell detachment assay was also performed to
assess the role of EspH during EPEC infection. HeLa cells were
infected with wild-type (WT) EPEC, espH EPEC, or espH
EPEC complemented with EspH (espH/pEspH) for 1 h and then
incubated for a further 3 h with gentamicin to stop bacterial rep-
lication. Treatment of cells with the apoptotic inducer staurospor-
ine (STS) for 5 h was used as a positive control. Quantification of
cells postinfection showed that 11.0 9.5% of cells infected with
wild-type EPEC were detached (Fig. 1C). In contrast, only 2.9 
8.7% of cells were detached following infectionwithespH EPEC.
Complementation of the mutant with a plasmid-encoded EspH
dramatically increased the level of cell detachment relative to that
of the STS control, as 51.1  1.8% of cells infected with espH/
pEspH EPEC were detached.
The contribution of EspH to cytotoxicity during EPEC infec-
tionwas alsomeasured by LDHrelease, which results fromplasma
membrane damage. Treatment of cells with STS for 5 hwas used as
a positive control. Infection with wild-type EPEC resulted in a
slightly higher LDH release than did infection with the espH
mutant (Fig. 1D). Complementation of the espHmutant signif-
icantly increased LDH release to levels comparable to those ob-
served with the STS control. EspH is thus a potent inducer of
cytotoxicity and cell detachment.
The phenotype of cell rounding and cell detachment led us to
examine whether EspHhad an effect on focal adhesions. To inves-
tigate this, we performed a time course study ofHeLa cells infected
with espH/pEspH EPEC, as this strain gave the most distinct
phenotype compared to wild-type EPEC or espH EPEC. When
coverslips were fixed hourly for 3 h and vinculin was used as a
marker for focal adhesions, immunofluorescence microscopy re-
vealed that EspH progressively induces disassembly of focal adhe-
sions concomitantly with actin disruption; no focal adhesions
were observed when cells were rounded at the end of infection
(Fig. 1E).
EspH mediates focal adhesion disassembly in a caspase-
independent manner. Inhibition of Rho GTPase signaling is also
a trigger for caspase activation and apoptosis (18), and the EspH-
mediated focal adhesion disassembly observed could therefore be
a result of caspase-mediated cleavage of focal adhesion proteins
(19). The ability of EspH to induce caspase-3 activation was tested
by infecting HeLa cells with WT, espH, or espH/pEspH EPEC
for 1 h and incubating them for a further 3 h in the presence of
gentamicin. Treatment of cells with STS for 5 h was used as a
positive control, and cleaved caspase-3 was detected by immuno-
fluorescence microscopy. In this assay, 61.1  0.8% of STS-
treated cells stained positive for active caspase-3, whereas only 2.9
 0.5% of untreated cells stained positive (Fig. 2A and B); 16.9
3.7% of WT EPEC-infected cells stained positive for caspase-3
activation, compared to 9.7  2.1% of cells infected with the
espH mutant (Fig. 2A and B). Complementation of the espH
mutant with plasmid-encoded EspH significantly increased
caspase-3 activation, as 29.0 1.6% of cells infected with espH/
pEspH EPEC stained positive for active caspase-3 (Fig. 2A and B).
To determine if EspH alone was sufficient to induce caspase-3
activation, cleaved caspase-3 was detected in cells ectopically ex-
pressing EspH (Myc-EspH) or Myc-tagged GFP (Myc-GFP) for
24 h.We observed that while 35.9 8.7%of cells expressing EspH
stained positive for active caspase-3, only 1.9  0.8% of GFP-
expressing cells exhibited the presence of cleaved caspase-3 (Fig.
2C and D).
We then used the pan-caspase inhibitor zVAD-fmk to assess
the levels of cell detachment following infection with espH/
pEspH EPEC (Fig. 2E). STS was again used as a control, and as
expected, STS-induced cell detachment was inhibited by zVAD-
fmk, as it is caspase mediated (cell detachment was reduced from
53.9 3.1% to 11.6 2.6% in the presence of zVAD-fmk). How-
ever, treatment with zVAD-fmk did not diminish cell detachment
induced by infection with espH/pEspH EPEC (62.3 3.1% cell
detachment without and 53.0  2.2% cell detachment with
zVAD-fmk). Immunofluorescence microscopy of espH/pEspH
EPEC-infected cells treated with zVAD-fmk further showed that
cells were still rounded, and no focal adhesions (vinculin) were
observed after a 3-h infection (Fig. 2F). These results suggest that
EspH-induced cell detachment was a result of FA disassembly
rather than caspase activation.
FAKis involved inEspH-inducedcell rounding,detachment,
and caspase-3 activation.As FAK regulates localized RhoGTPase
activity and focal adhesion dynamics (3), we investigated if FAK is
involved in EspH-induced cell rounding and caspase-3 activation.
FAK-null (FAK/) and FAK-reconstituted (FAK/) fibroblasts
were transfected with Myc-tagged EspH or Myc-tagged GFP as a
control and stained for F actin and cleaved caspase-3. Immuno-
fluorescence microscopy revealed that EspH induced cell round-
ing and caspase-3 activation in FAK/ fibroblasts (Fig. 3A to C).
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FIG 1 EspH induces cell detachment, cytotoxicity, and focal adhesion disassembly. (A) Quantification of cell rounding of HeLa cells transfected withMyc-GFP
or Myc-EspH for 24 h. One hundred transfected cells were counted in triplicate. Ectopic expression of EspH induced a significant increase in cell rounding
compared to GFP expression. Results are means plus standard deviations (SD) of three independent experiments. (B) Quantification of detachment levels of
HeLa cells transfected with Myc-GFP or Myc-EspH for 24 h. Ectopic expression of EspH induced a significant increase in cell detachment compared to GFP.
Results aremeans plus SDs of three independent experiments. **, P 0.01. (C)Quantification of detachment levels of HeLa cells infected withWTEPEC,espH
EPEC, orespHEPEC complementedwith EspH (espH/pEspH) for 1 h and then incubatedwith gentamicin for 3 h. STS treatment ofHeLa cells for 5 hwas used
as a positive control. Cell detachmentwas expressed as a percentage of the value for uninfected cells. Cell detachmentwas reduced in theespHmutant compared
toWT EPEC. Complementation with EspH increased cell detachment to STS levels. Results are means SD of three independent experiments. *, P 0.05; **,
P 0.01. (D) Quantification of cytotoxicity to HeLa cells infected withWT EPEC,espH EPEC, orespH EPEC complemented with EspH (espH/pEspH) for
30 min and then incubated with gentamicin for 4 h. STS treatment of HeLa cells for 5 h was used as a positive control. Cytotoxicity was assayed by quantifying
the levels of LDH release into the culture supernatant from cells 4 h postinfection. Results are means SD of three independent experiments. (E) Immunoflu-
orescence microscopy of HeLa cells infected with espH EPEC complemented with EspH (espH/pEspH) for 0, 60, 120, and 180 min. Bacteria were visualized
with anti-intimin antibody (magenta), vinculin was detected with anti-vinculin antibody (green), and actin was stained with TRITC-phalloidin (red). Infection
with espH/pEspH EPEC progressively induced focal adhesion disassembly, as cells were rounded after 180 min of infection. Bar 10 m.
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FIG 2 EspH induces focal adhesion disassembly in a caspase-independent manner. (A) Immunofluorescence microscopy of uninfected HeLa cells or cells
infected withWT EPEC,espH EPEC, orespH EPEC complemented with EspH (espH/pEspH) for 1 h, then incubated with gentamicin for 3 h. Bacteria were
visualized with anti-intimin antibody (green), active caspase-3 was detected with anti-caspase-3 (cleaved) antibody (magenta), actin was stained with TRITC-
phalloidin (red) and cell nuclei were stained with DAPI (cyan). The espH mutant induced reduced levels of caspase-3 activation compared to WT EPEC.
Complementationwith EspH resulted in amarked increase in caspase-3 activationwhen compared toespH alone. Bar 20m. (B)Quantification of caspase-3
activation of infected cells from (A). STS treatment of HeLa cells for 5 h was used as a positive control. 100 infected cells were counted in triplicates. Results are
means SD of three independent experiments. *, P 0.05), ***, P 0.001). (C) Immunofluorescence microscopy of HeLa cells transfected with Myc-GFP or
Myc-EspH. Myc-tagged proteins were visualized with anti-Myc antibody (green), active caspase-3 was detected with anti-caspase-3 (cleaved) antibody (ma-
genta), actin was stained with TRITC-phalloidin (red) and nuclei were stained with DAPI (cyan). Ectopic expression of EspH, but not GFP, induced caspase-3
activation. Bar 20m. (D)Quantification of caspase-3 activation of transfected cells from (C). STS treatment ofHeLa cells for 5 hwas used as a positive control.
100 transfected cells were counted in triplicates. Results aremeans SDof three independent experiments. **,P 0.01). (E)Quantification of detachment levels
of HeLa cells, with or without zVAD-fmk treatment, infected with espH EPEC complemented with EspH (espH/pEspH) for 1 h, then incubated with
gentamicin for 3 h. STS treatment ofHeLa cells for 5 hwas used as a positive control. Cell detachmentwas expressed as a percentage of uninfected cells. Treatment
with zVAD-fmk inhibited STS-induced cell detachment, but not cell detachment following infection withespH/pEspH EPEC. Results are means SD of three
independent experiments. (F) Immunofluorescencemicroscopy ofHeLa cells infectedwithespHEPEC complementedwith EspH (espH/pEspH) for 180min,
with orwithout zVAD-fmk treatment. Bacteria were visualizedwith anti-intimin antibody (magenta), vinculinwas detectedwith anti-vinculin antibody (green),
and actin was stained with TRITC-phalloidin (red). Treatment with zVAD-fmk did not prevent focal adhesion disassembly. Bar 10 m.
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In contrast, FAK/ fibroblasts exhibited reduced levels of cell
rounding and little caspase-3 activation (Fig. 3A to C). As FAK/
fibroblasts were resistant to EspH-induced cell rounding, the role
of FAK on cell adhesion during EPEC infection was examined.
FAK/ and FAK/ fibroblasts were assessed for levels of cell
detachment following infection with wild-type,espH, orespH/
pEspH EPEC. STS treatment was used as a control and showed
similar levels of cell detachment in
FAK/ and FAK/ fibroblasts (Fig.
3D). Consistent with the results described
above, FAK/ fibroblasts did not show
any significant levels of cell detachment
after infection with any of the strains (Fig.
3D). In contrast, 43.2 9.5%of cells were
detached following infection of FAK/
fibroblasts withespH/pEspHEPEC (Fig.
3D). Taken together, our results show
that FAK is an important mediator of
EspH-induced cell rounding and cell de-
tachment and suggest that defects in focal
adhesion disassembly diminish the ability
of EspH to induce cell rounding and
caspase-3 activation.
Bacterial RhoGEFs are active in the
presence of EspH. We next investigated
whether, in addition to blocking mam-
malian DH-PH RhoGEFs, EspH inhibits
the activity of bacterial RhoGEFs. HeLa
cells transfected with Myc-tagged EspH
or Myc-tagged GFP were infected with
map/pMap EPEC for 30 min or with
EPEC/pEspT or EPEC/pEspM2 for 90
min and assessed for filopodium, lamelli-
podium, and stress fiber formation, re-
spectively. For consistency, we deleted en-
dogenous map so that all three effectors
were expressed exclusively from inducible
genes. Staining with F actin revealed that
cells infected with EPEC expressing the
WxxxE effectors were able to induce for-
mation of their respective actin structures
in cells transfected with either GFP or
EspH (Fig. 4A). This suggests that EspH
does not inhibit the activity of the
WxxxE-family RhoGEFs during EPEC in-
fection.
To affirm this observation, cells were
cotransfected with red fluorescent pro-
tein (RFP) or RFP-EspH andMyc-tagged
Map, EspT, EspM2, or the catalytic region
of SopE (SopE78-240); cotransfection with
Myc-tagged p115-RhoGEF, a mamma-
lian RhoA GEF which has been shown to
bind EspH (7), was used as a control. Af-
ter staining for F actin, we observed that
EspH was able to inhibit stress fiber for-
mation by p115-RhoGEF, and the
cotransfected cells were rounded (Fig.
4B). In contrast, cotransfection of RFP-
EspHwithMap, EspT, EspM2, or SopE78-
240 did not inhibit formation of filopodia (Map), lamellipodia
(EspT/SopE), or stress fibers (EspM2) (Fig. 4B; also, see Fig. S1 in
the supplemental material). When cotransfected with RFP, the
RhoAGEFs p115-RhoGEF and EspM2 induced stress fiber forma-
tion in 79.7  3.3% and 90.6  1.1% of cells, respectively (Fig.
4C). When cotransfected with RFP-EspH, p115-RhoGEF showed
markedly reduced stress fiber formation, with only 14.5 2.8%of
FIG 3 FAK is involved in EspH-induced cell rounding, detachment, and caspase-3 activation. (A)
Immunofluorescence microscopy of FAK/ or FAK/ fibroblasts transfected with Myc-GFP or
Myc-EspH. Myc-tagged proteins were visualized with anti-Myc antibody (green), active caspase-3 was
detected with anti-caspase-3 (cleaved) antibody (magenta), actin was stained with TRITC-phalloidin
(red), and cell nuclei were stainedwithDAPI (cyan). Ectopic expression of EspH induced cell rounding,
nuclear condensation, and caspase-3 activation in FAK/ cells but not FAK/ fibroblasts. Bar 20
m. (B)Quantification of cell rounding of FAK/ or FAK/fibroblasts transfectedwithMyc-GFPor
Myc-EspH. 100 transfected cells were counted in triplicates. Results are means plus SD of three inde-
pendent experiments. ***, P 0.001. (C) Quantification of caspase-3 activation of FAK/ or FAK/
fibroblasts transfected with Myc-GFP or Myc-EspH. One hundred transfected cells were counted in
triplicate. Results aremeans plus SDof three independent experiments. **,P 0.01. (D)Quantification
of detachment levels of FAK/ or FAK/ fibroblasts infected withWTEPEC,espH EPEC, orespH
EPEC complemented with EspH (espH/pEspH) for 1 h and then incubated with 200 g ml1 genta-
micin for 3 h. Treatment of FAK/ or FAK/ fibroblasts with 1 M staurosporine (STS) for 5 h was
used as a positive control. Cell detachment was expressed as a percentage of the value for uninfected
cells. Cell detachment was drastically reduced in FAK/ fibroblasts infected withWT EPEC orespH/
pEspH EPEC compared to that in FAK/ fibroblasts. Results are means plus SD of three independent
experiments. **, P 0.01.
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FIG 4 Bacterial RhoGEFs are active in the presence of EspH. (A) Immunofluorescence microscopy of HeLa cells transfected with Myc-GFP or Myc-EspH and
then infected with map/pMap EPEC for 30 min or EPEC expressing EspT (EPEC/pEspT) or EspM2 (EPEC/pEspM2) for 90 min. Myc-tagged proteins were
visualized with anti-Myc antibody (green), bacteria were visualized with anti-intimin antibody (magenta), and actin was stained with TRITC-phalloidin (red).
Ectopic expression of EspH did not inhibit the formation of filopodia (Map), lamellipodia (EspT), or stress fibers (EspM2). Bar 20 m. (B) Immunofluores-
cence microscopy of HeLa cells cotransfected with Myc-p115RhoGEF or Myc-EspM2 and with RFP or RFP-EspH (red). Myc-tagged proteins were visualized
with anti-Myc antibody (magenta), and actin was stained with Oregon green phalloidin (green). Cotransfection of Myc-p115RhoGEF and RFP-EspH but not
Myc-EspM2 and RFP-EspH drastically reduced stress fiber formation. Bar 20m. (C)Quantification of stress fiber formation inHeLa cells cotransfected with
Myc-p115RhoGEF or Myc-EspM2 and with RFP or RFP-EspH. One hundred cotransfected cells were counted in triplicate. Results are means plus SD of three
independent experiments. ***, P 0.001.
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cells displaying stress fibers. In contrast, only amodest decrease in
stress fiber formation was observed in cells cotransfected with
EspM2 and RFP-EspH, as 76.5  2.1% of cells were positive for
stress fibers (Fig. 4C). Taken together, these results demonstrate
that bacterial RhoGEFs are insensitive to EspH.
EspT, EspM2, and SopE block EspH-induced cell detach-
ment and focal adhesiondisassembly.Next, we determined if the
bacterial RhoGEFs couldmitigate the detrimental effects of EspH.
To investigate if bacterial RhoGEFs could block EspH-induced
cell detachment, we transfected HeLa cells with Myc-tagged bac-
terial RhoGEFs or their respective Rho GTPase dominant posi-
tives as controls and then infected themwithespH/pEspH EPEC
for 1 h, followed by gentamicin treatment for a further 3 h. No
construct induced significant levels of cell detachment by trans-
fection alone compared to theMyc-GFP control (Fig. 5). Infection
of Myc-GFP-transfected cells with espH/pEspH EPEC resulted
in 55.6 5.1%detachment (Fig. 5). Interestingly, cells transfected
with the Rac1-activating effectors EspT and SopE78-240 and
dominant-positive Rac1 (Rac1L61) showed a significant reduc-
tion in cell detachment following infection with espH/pEspH
EPEC, as only 30.3 6.7%, 30.6 2.8%, and 34.4 4.2% of cells
were detached, respectively (Fig. 5).We also observed an interme-
diate reduction in cell detachment of cells transfected with
dominant-positive RhoA (RhoAL63) and its corresponding GEF
EspM2, as 43.1  2.7% and 35.0  6.4% of cells were detached,
respectively (Fig. 5). Neither the Cdc42 GEF Map nor dominant
positive Cdc42 (Cdc42L61) could inhibit cell detachment follow-
ing infection with espH/pEspH EPEC, as 53.7  11.2% and
52.7% 4.9% of cells were detached, respectively (Fig. 5). These
results imply that Cdc42 activation alone is unable to block EspH-
induced cell detachment.
We next examined if EspT, EspM2, and SopE also inhibited
EspH-induced focal adhesion disassembly. In contrast to GFP-
and Map-transfected cells, EspT- and SopE78-240-transfected cells
blocked EspH-induced cell rounding, and vinculin staining re-
vealed that large focal adhesions were still present in a radial pat-
tern following infection with espH/pEspH EPEC (see Fig. S2 in
the supplemental material). EspM2-transfected cells also retained
stress fiber-associated focal adhesions following infection with
espH/pEspH EPEC (see Fig. S2). These results suggest that Rac1
and RhoA activation is critical for inhibition of EspH-induced cell
detachment and focal adhesion disassembly.
EspT, EspM2, andSopE inhibit caspase-3 activation.Wenext
investigated if the bacterial RhoGEFs could also block EspH-
induced caspase-3 activation.When the transfection-infection de-
livery strategy described above was used, espH/pEspH EPEC in-
duced caspase activation in 33.0  8.5% of cells transfected with
the GFP control (Fig. 6; also, see Fig. S3 in the supplemental ma-
terial). Map was unable to inhibit EspH-induced caspase-3 acti-
vation, as 32.1  6.7% of transfected cells were positive for
caspase-3 activation. In contrast, EspT, EspM2, and SopE78-240
inhibited EspH-induced caspase-3 activation, as only 8.3 2.8%,
13.9  3.3%, and 9.2  2.2% of transfected cells, respectively,
were positive for caspase-3 activation (Fig. 6; also, see Fig. S3).
As Rho GTPases play a role in cell survival (1), we investigated
if the bacterial RhoGEFs could play an additional role in inhibiting
apoptosis. To investigate this, we transfectedHeLa cells withMyc-
tagged Map, EspT, EspM2, and SopE78-240 and treated them with
STS for 5 h. Transfection of anti-apoptotic Myc-tagged NleH1,
which inhibits caspase-3 activation induced by STS (20), was used
as a control. Quantification of cleaved caspase-3 by immunofluo-
rescence revealed that cells transfected with the Myc-GFP control
or Map displayed high levels of cleaved caspase-3 (Fig. 7; also, see
Fig. S4 in the supplemental material). In contrast, cells transfected
withMyc-tagged EspT, EspM2, or SopE78-240 all showed amarked
FIG 5 EspT, EspM2, and SopE block EspH-induced cell detachment. Detach-
ment levels in HeLa cells transfected with Myc-GFP or Myc-tagged bacterial
RhoGEFs, uninfected or infected with EPEC with espH complemented with
EspH (espH/pEspH) for 1 h, followed by incubation with 200 g ml1 gen-
tamicin for 3 h, were quantified. Transfection with dominant-positive Cdc42
(Cdc42L61), Rac1 (Rac1L61), and RhoA (RhoAL63) was used as positive con-
trols. Cell detachment was expressed as a percentage of that in nontransfected,
noninfected cells. Ectopic expression of Myc-tagged EspT, EspM2, or SopE78-
240 resulted in reduced cell detachment following infection withespH/pEspH
EPEC but not Myc-tagged GFP or Map. Results are means plus SD of three
independent experiments. Statistical significance is based on a Student’s t test
compared to the Myc-GFP control. *, P 0.05; **, P 0.01.
FIG 6 EspT, EspM2, and SopE inhibit EspH-induced caspase-3 activation.
Caspase-3 activation of HeLa cells transfected with Myc-GFP or Myc-tagged
bacterial RhoGEFs, uninfected or infected with EPEC with espH comple-
mented with EspH (espH/pEspH) for 1 h, followed by incubation with 200
g/ml gentamicin for 3 h, was quantified. One hundred transfected cells were
counted in triplicate. Ectopic expression of Myc-tagged EspT, EspM2, or
SopE78-240markedly reduced caspase-3 activation in cells infectedwithespH/
pEspH EPEC but not Myc-tagged GFP or Map. Results are means plus SD of
three independent experiments. Statistical significance is based on a Student’s
t test compared to the Myc-GFP control. *, P 0.05; **, P 0.01.
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reduction in levels of cleaved caspase-3 similar to that seen in cells
transfected with anti-apoptotic effector NleH (Fig. 7; also, see Fig.
S4).
To demonstrate the role of EspT and EspM2 in promoting cell
survival during EPEC infection, we utilized a nleH1 nleH2
EPECmutant that induces high levels of apoptosis upon infection
(20).We infectedHeLa cells withwild-type EPEC,nleH1nleH2
EPEC, or nleH1 nleH2 EPEC expressing plasmid-encoded
NleH1 (positive control), EspT, EspT(W63A) (defective in Rac1
activation), EspM2, or EspM2(W70A) (defective in RhoA activa-
tion) and assessed the levels of caspase-3 activation, cell detach-
ment, and cytotoxicity (see Fig. S5 in the supplemental material).
Intriguingly, EspT and EspM2, but not EspT(W63A) or
EspM2(W70A), partially restored the wild-type phenotype in
terms of caspase-3 activation, cell detachment, and cytotoxicity
(see Fig. S5). Taken together, these results show that EspT and
EspM2 are able to inhibit EspH- and STS-induced caspase-3 acti-
vation and promote cell survival dependent on Rac1 or RhoA
activation during EPEC infection.
DISCUSSION
Several roles have been described for SopE and the WxxxE bacte-
rial RhoGEFs, including actin remodeling, bacterial invasion, in-
nate host cell response, and tight junction disruption (reviewed in
reference 6). In this study, we expanded the repertoire of bacterial
RhoGEF functions to include promotion of cell adhesion and sur-
vival. We also found that bacterial RhoGEFs are resistant to the
DH-PH mammalian RhoGEF inhibitor EspH. EPEC and EHEC
are thus able to neutralizemammalian RhoGEFs while translocat-
ing their own bacterial RhoGEFs to hijack Rho GTPase signaling
for the proprietary benefit of the pathogen.
Bacterial pathogens manipulate Rho GTPase signaling in a co-
ordinated, spatiotemporal manner. Yersinia translocates several
T3SS effectors that inactivate Rho GTPases: YopE is a RhoGAP
(21), YopT is a cysteine protease that cleaves Rho GTPases to
prevent membrane localization (22), and YpkA/YopO has a
RhoGDI activity (23). Vibrio parahaemolyticus delivers VopS,
which contains a Fic domain that inactivates Rho GTPases
through AMPylation (24). Salmonella enterica serovar Typhimu-
rium temporally regulates Cdc42 andRac1 by delivering SopE and
SptP. SopE activates Cdc42/Rac1 to induce the “trigger mecha-
nism” of bacterial invasion but is quickly degraded (25). SptP
exhibits GAP activity but slower degradation kinetics, thus allow-
ing recovery from SopE-induced membrane ruffling (25).
While EPEC and EHEC translocate several WxxxE RhoGEFs,
thus far no effector with RhoGAP activity has been identified (26).
Instead, EPEC uses a novel strategy by which EspH globally inhib-
its mammalian DH-PH RhoGEFs (7). The WxxxE effector Map
triggers transient Cdc42-dependent filopodium formation at the
site of bacterial attachment (15) before re-localizing to the mito-
chondria via its N-terminal mitochondrial targeting sequence
(27). Filopodium dynamics is spatially regulated by Map interac-
tion, through its carboxy-terminal PSD-95/Disk-large/ZO-1
(PDZ)-bindingmotif (DTRL), with the scaffold proteins sodium-
hydrogen exchanger regulatory factors 1 and 2 (NHERF1/2) at the
cell surface (8, 9, 28). In addition, the RhoA/ROCK pathway has
been implicated in control of Map-induced filopodium dynamics
(16). As Map was still able to induce filopodia in the presence of
EspH, it is unlikely that EspH directly affectsMapGEF activity for
Cdc42. Rather, we speculate that EspH inhibits Map-induced
filopodia by inhibiting the RhoA/ROCK pathway.
Indeed, the ability of EspH to induce cell rounding, focal ad-
hesion disassembly, and caspase-3 activation is reminiscent of
clostridial toxin B (TcdB) intoxication (18). This is not surprising
given the fact that EspH, like TcdB, inactivates Rho GTPases, al-
though TcdB directly targets Rho GTPases and inactivates them
by glucosylation of Thr-37 (reviewed in reference 29). Signifi-
cantly, we show that the ability of EPEC to antagonize EspH is
mediated by the WxxxE effectors EspT and EspM2 and that nei-
ther Map nor Cdc42 activation was able to block EspH-induced
cell detachment or caspase-3 activation. While it was previously
reported that Map induces mitochondrial dysfunction (27), we
did not observe any significant Map-induced cell detachment or
caspase-3 activation by transfection. Consistent with our findings
that Rac1 and RhoA activation are sufficient to inhibit EspH-
induced cell detachment and caspase-3 activation, we also found
that FAK, which coordinates the activities of Rac1 and RhoA to
regulate focal adhesion dynamics, is an important mediator of
EspH-induced cell rounding, cell detachment, and caspase-3 ac-
tivation. As EspT and SopE are unable to trigger lamellipodium
formation in FAK/ fibroblasts (data not shown), our results
support a model in which EPEC and EHEC utilize EspH and bac-
terial RhoGEFs to mediate focal adhesion dynamics through sub-
version of FAK signaling pathways.
Intriguingly, EspT, EspM2, and SopE (but not Map) can also
inhibit STS-induced caspase-3 activation to the same extent as the
anti-apoptotic effector NleH. In addition, EspT and EspM2 pro-
mote host cell survival during EPEC infection. Indeed, several
reports have demonstrated that Rac1- and RhoA-activating Rho-
GEFs are able to activate mitogen-activated protein kinase
(MAPK) and NF-B pathways (30–32), which have pivotal roles
in the regulation of cell survival (33, 34). As FAK-mediated signal-
ing cascades are also involved in the regulation of cell survival by
FIG 7 EspT, EspM2, and SopE inhibit staurosporine-induced caspase-3 ac-
tivation. Caspase-3 activation ofHeLa cells transfectedwithMyc-GFP orMyc-
tagged bacterial RhoGEFs and then treated with 1Mstaurosporine (STS) for
5 h was quantified. Transfection of Myc-NleH1 and Myc-NleH2 was used as
positive controls. One hundred transfected cells were counted in triplicate.
Ectopic expression of Myc-tagged EspT, EspM2, or SopE78-240 markedly re-
duced caspase-3 activation in cells treated with STS compared to expression of
NleH effectors but not Myc-tagged GFP orMap. Results are means plus SD of
three independent experiments. Statistical significance is based on a Student’s
t test compared to the Myc-GFP control. **, P 0.01.
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bacterial RhoGEFs, more work is required to dissect the mecha-
nisms by which WxxxE-family effectors are able to modulate the
cell death response. Thus, in characterizing the interplay between
EspH and bacterial RhoGEFswe found that EPEC and EHEChave
evolved sophisticated mechanisms to subvert Rho GTPase signal-
ing pathways in a functionally coordinated manner.
MATERIALS AND METHODS
Bacterial strains and plasmids. Strains, plasmids, and primers are listed
in Tables S1, S2, and S3, respectively, in the supplemental material. Bac-
teria were grown from single colonies in Luria-Bertani (LB) broth in a
shaking incubator at 37°C. Culture medium or agar was supplemented
with ampicillin (100 g ml1), chloramphenicol (34 g ml1), or kana-
mycin (50 g ml1) as appropriate. Bacterial cultures were primed for
infection by dilution of 1:50 of overnight bacterial culture with pre-
warmed Dulbecco’s minimal Eagle medium (DMEM) with low glucose
(1,000 mg liter1) (Sigma) and incubated as static cultures at 37°C in 5%
CO2 for 3 h. Static cultures were induced with 1 mM isopropyl thiogalac-
topyranoside (IPTG) for pSA10 effector expression 30min prior to infec-
tion.
Molecular cloning. The espH gene of E2348/69 was amplified by PCR
using the primer pair EcoRI-EspH-E69-Fw–PstI-EspH-E69-Rv, BamHI-
EspH-E69-Fw–PstI-EspH-E69-Rv, or HindIII-EspH-E69-Fw–EcoRI-
EspH-E69-Rv and cloned into the pSA10, pRK5myc, or pCMV-RFP vec-
tor to generate pICC1098, pICC529, and pICC1099, respectively. All
constructs were verified by DNA sequencing.
Tissue culture, transfection, and infection with EPEC E2348/69.
HeLa (ATCC), FAK/ (ATCC), and FAK/ (ATCC) cells were grown
at 37°C in a humidified atmosphere containing 5% CO2 in DMEM with
low glucose (1,000 mg liter1) (Sigma) supplemented with 10% (vol/vol)
heat-inactivated fetal bovine serum (Gibco) and 2 mM GlutaMAX
(Sigma). Cells were grown in 24-well cell culture plates to 80% conflu-
ence. HeLa cells were transfected with mammalian expression vectors
using Fugene 6 (Roche) according to the manufacturer’s instructions.
FAK/ or FAK/ cells were transfected with mammalian expression
vectors using Lipofectamine 2000 (Invitrogen) according to themanufac-
turer’s instructions. Transfected cells were incubated at 37°C in a humid-
ified incubator with 5% CO2 for 24 h prior to infection. For EPEC infec-
tion, HeLa cells were washed twice with phosphate-buffered saline (PBS)
and then infected with primed bacterial culture (multiplicity of infection
[MOI], 1:100) at 37°C in a humidified atmosphere containing 5%CO2 for
the appropriate time or treatment. Coverslips were washed three times in
PBS and fixed with 3% paraformaldehyde for 15 min before being pro-
cessed for immunofluorescence microscopy.
Pharmacology. Staurosporine (STS) (Calbiochem) was used at a final
concentration of 1 M for 5 h to induce apoptosis. The pan-caspase in-
hibitor zVAD-fmk (Promega) was used at a final concentration of 66M
(together with bacteria or with STS).
Immunofluorescence microscopy. Cells were quenched for 15 min
with 50 mM NH4Cl and then permeabilized for 5 min in PBS–0.2% Tri-
ton X-100. Coverslips were washed three times in PBS and blocked in
PBS–1% BSA for 10 min before addition of primary antibodies. Cover-
slips were incubated with primary antibodies diluted in PBS–1% BSA for
1 h. For caspase-3 staining, primary antibodies were incubated overnight
at 4°C. After three washes with PBS, coverslips were incubated with sec-
ondary antibodies diluted in PBS–1% BSA for a further 1 h. Coverslips
were washed three times with PBS and once in water before being
mounted in gold Pro-Long antifade medium (Invitrogen) and examined
by conventional epifluorescence microscopy using a Zeiss Axio LSM-510
microscope. Images were deconvoluted and processed using AxioVision
4.8 LE software (Zeiss) and Adobe Photoshop CS4.
Antibodies. Actin was detected with Oregon green-conjugated phal-
loidin antibody (1:100 dilution) (Invitrogen) or tetramethyl rhodamine
isothiocyanate (TRITC)-conjugated phalloidin (1:500 dilution) (Sigma).
Intimin was labeled with polyclonal chicken anti-intimin antibody serum
(1:200 dilution) (kindly provided by Roberto La Ragione). DNA was
stained with 4=,6-diamidino-2-phenylindole (DAPI) (1:1,000 dilution).
Cleaved caspase-3 (active) was detected using rabbit anti-cleaved
caspase-3 antibody (1:50 dilution) (Cell Signaling). Vinculin was visual-
ized using mouse antivinculin antibody (1:200 dilution) (Abcam). Myc-
tagged proteins were labeled with mouse anti-Myc antibody (1:500 dilu-
tion) (Millipore). Cy2-, RRX-, or Cy5-conjugated donkey anti-mouse,
anti-chicken, or anti-rabbit antibodies (1:200 dilution) (Jackson Immu-
noResearch) were used as secondary antibodies.
Cell detachment assay. HeLa cells grown in 24-well plates were in-
fected for 1 h (MOI, 1:100) and then treated with 200gml1 gentamicin
(Sigma) for a further 3 h. Cells were washed five times with PBS and then
trypsinized; trypsin was inactivated with culture medium. Cells were
counted using a Neubauer hemocytometer. Counts were expressed as a
percentage of uninfected cells and plotted as a graph of percent detached
cells.
Cytotoxicity assay. HeLa cells grown in 96-well plates were infected
with primed bacterial culture (MOI, 1:200) in phenol red-free DMEM
and centrifuged for 4 min at 200 g to synchronize infection. Cells were
incubated for 30min, washed oncewith PBS, and then incubatedwith 200
g ml1 gentamicin (Sigma) in phenol red-free DMEM for a further 4 h.
LDH release during EPEC infection was assayed using a CytoTox96 cyto-
toxicity assay kit (Promega) according to themanufacturer’s instructions.
Cytotoxicity was calculated as follows: [(experimental LDH activity 
basal LDH activity)/(total LDH activity basal LDH activity)] 100.
Statistical analysis. Results were expressed as means and standard
deviations. Statistical significance was determined by a two-tailed Student
t test. A P value of0.05,0.01, or0.001 was considered significant.
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